0001209191-19-021612.txt : 20190328 0001209191-19-021612.hdr.sgml : 20190328 20190328154608 ACCESSION NUMBER: 0001209191-19-021612 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190328 FILED AS OF DATE: 20190328 DATE AS OF CHANGE: 20190328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: TOKICH MICHAEL J CENTRAL INDEX KEY: 0001235611 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38848 FILM NUMBER: 19711794 MAIL ADDRESS: STREET 1: C/O STERIS CORP STREET 2: 5960 HEISLEY RD CITY: MENTOR STATE: OH ZIP: 44060 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: STERIS Ltd CENTRAL INDEX KEY: 0001757898 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 000000000 STATE OF INCORPORATION: L2 FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 70 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN STATE: L2 ZIP: 2 BUSINESS PHONE: 35312322454 MAIL ADDRESS: STREET 1: 70 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN STATE: L2 ZIP: 2 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-03-28 0 0001757898 STERIS Ltd STE 0001235611 TOKICH MICHAEL J C/O 70 SIR JOHN ROGERSON'S QUAY DUBLIN L2 2 IRELAND 0 1 0 0 Sr. Vice Pres., CFO Ordinary Shares 2019-03-28 4 A 0 50458 A 50458 D Ordinary Shares 2019-03-28 4 A 0 3406 A 3406 I See Footnote Below Employee Stock Option (right to buy) 45.34 2019-03-28 4 A 0 22000 A 2023-05-31 Ordinary Shares 22000 22000 D Employee Stock Option (right to buy) 53.52 2019-03-28 4 A 0 28000 A 2024-05-30 Ordinary Shares 28000 28000 D Employee Stock Option (right to buy) 67.98 2019-03-28 4 A 0 20000 A 2025-08-10 Ordinary Shares 20000 20000 D Employee Stock Option (right to buy) 69.72 2019-03-28 4 A 0 30000 A 2026-06-01 Ordinary Shares 30000 30000 D Employee Stock Option (right to buy) 77.07 2019-03-28 4 A 0 32000 A 2027-05-30 Ordinary Shares 32000 32000 D Employee Stock Option (right to buy) 114.22 2019-03-28 4 A 0 46664 A 2028-05-31 Ordinary Shares 46664 46664 D 25,940 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 4,000 on October 1, 2019; 4,700 on June 1, 2020; 6,000 on June 1, 2021; and 4,240 on May 31, 2022. Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Units representing 3,406 ordinary share equivalents are held on behalf of the Reporting Person under the STERIS Corporation 401(k) Plan as of March 27, 2019. This option to purchase 22,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 22,000 Old STERIS ordinary shares for $45.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. This option to purchase 28,000 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 28,000 Old STERIS ordinary shares for $53.52 per share, subject to the same terms and conditions as the original Old STERIS stock option This option becomes exercisable as follows: 5,000 on May 28, 2016; 5,000 on May 28, 2017; 5,000 on May 28, 2018 and 5,000 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 20,000 STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option. This option becomes exercisable as follows: 7,500 on June 1, 2017; 7,500 on June 1, 2018; 7,500 on June 3, 2019 and 7,500 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 30,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. This option becomes exercisable as follows: 8,000 on May 30, 2018; 8,000 on May 30, 2019; 8,000 on June 1, 2020 and 8,000 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 32,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. This option becomes exercisable as follows: 11,666 on May 31, 2019; 11,666 on June 1, 2020; 11,666 on June 1, 2021 and 11,666 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 46,664 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. /s/ Ronald E. Snyder, Authorized Representative under Power of Attorney 2019-03-28